Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

French court rejects claim for 'Agent Orange' damage in Vietnam war

Published 05/10/2021, 11:10 AM
Updated 05/11/2021, 05:29 AM
© Reuters. Tran To Nga, a French-Vietnamese woman, who claims she was a victim of Agent Orange, attends a news conference in Paris, the day after a French court threw out her lawsuit against more than a dozen multinationals that produced and sold the toxic herbicide used by U.S. troops during the war in Vietnam, France, May 11, 2021.  REUTERS/Sarah Meyssonnier

By Dominique Vidalon and Yiming Woo

PARIS (Reuters) - A French court on Monday threw out a lawsuit by a French-Vietnamese woman against more than a dozen multinationals that produced and sold a toxic herbicide dubbed "Agent Orange", used by U.S. troops during the war in Vietnam.

Filed in 2014, the case has pitched Tran To Nga, a 79-year-old who claims she was a victim of Agent Orange, against 14 chemical firms, including U.S. companies Dow Chemical and Monsanto (NYSE:MON), now owned by Germany's Bayer (OTC:BAYRY).

Tran To Nga told Reuters the case had been thrown out but that she would appeal.

Tran, who worked as a journalist and activist in Vietnam in her 20s, has said she was suffering from effects including type 2 diabetes and a rare insulin allergy.

U.S. warplanes dropped about 18 million gallons (68 million litres) of Agent Orange - so-called because it was stored in drums with orange bands - between the early 1960s and early 1970s to defoliate jungles and destroy Viet Cong crops.

MULTINATIONALS SAY NOT RESPONSIBLE

The multinationals had argued they could not be held responsible for use the U.S. military made of their product.

The court ruled it did not have jurisdiction to judge a case involving the U.S. government's wartime actions, Agence France Presse reported. Reuters could not immediately see the ruling.

One of Tran's lawyers, William Bourdon, said in a statement on Twitter that the court was applying an obsolete definition of the immunity of jurisdiction principle which contradicted modern principles of international and national law.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

He said it was "astounding" that the court had backed the companies' contention that they were acting on orders when responding to U.S. government tenders for contracts.

In a statement, Bayer said it welcomed the court's decision while saying it had "great sympathy for Ms. Tran To Nga and all those who suffered during the Vietnam war".

But it said it had been "well-established by courts for many years that wartime contractors like the nine former manufacturers, operating at the behest of the U.S. government, are not responsible for the alleged damage claims associated with the government's use of such product during wartime".

So far, only military veterans from the United States and other countries involved in the war have won compensation over Agent Orange. In 2008, a U.S. federal appeals court upheld the dismissal of a civil lawsuit against major U.S. chemical companies brought by Vietnamese plaintiffs.

The United States has maintained there is no scientifically proven link between the wartime spraying and the claims of dioxin poisoning of many Vietnamese.

Latest comments

She has to prove that the companies knew the intention to win the case. Otherwise, she is wasting her money n time to have a 5min fame.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.